
Voglidac 0.2 Tablet MD
Marketer
Daksh Pharma Pvt Ltd
Salt Composition
Voglibose (0.2mg)
Overview Voglidac 0.2 Tablet MD
Diabetol 0.2mg tablets are prescribed for managing type 2 diabetes. This medication assists in regulating postprandial hyperglycemia (high blood sugar after meals), particularly when dietary adjustments and other similar medications prove insufficient. Diabetol 0.2mg should be administered immediately before meals. Dosage and frequency are determined individually by your physician to optimize blood glucose control. Discontinuing this medication abruptly is unsafe and may result in dangerously elevated blood sugar, potentially leading to complications such as renal impairment or vision loss. Successful treatment requires adherence to a comprehensive plan including a healthy diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is crucial. Common side effects include abdominal discomfort, gas, appetite changes, constipation, and diarrhea. Report any persistent or bothersome side effects to your physician. While Diabetol 0.2mg alone does not induce hypoglycemia (low blood sugar), concurrent use with other diabetes medications (especially insulin or sulfonylureas) increases this risk. If hypoglycemia occurs, treat it with plain glucose; table sugar is ineffective in this context. Inform your doctor of any liver or kidney issues before commencing treatment. This medication is contraindicated in individuals with bowel inflammation or ulceration (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals should seek medical advice before use. Always disclose all other medications to your doctor to ensure safety. Limit alcohol consumption, as it can heighten the risk of hypoglycemia.
Uses of Voglidac 0.2 Tablet MD
Managing type 2 diabetes
Major Benefits of Voglidac 0.2 Tablet MD:
Administer this medication precisely as your physician directs, adhering to both dosage and treatment length. Avoid contact with the tablets using damp hands. Place the tablet in your mouth, but refrain from swallowing immediately. The Voglidac 0.2mg tablet should be ingested on an empty stomach.
Common Side effects of Voglidac 0.2 Tablet MD:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglidac 0.2 Tablet MD:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Avoid handling the tablets with damp hands. Place the tablet in your mouth, but refrain from swallowing immediately. Consume Voglidac 0.2 mg Tablet MD on an empty stomach.
How Voglidac 0.2 Tablet MD works:
Voglidac 0.2 mg tablets are used to manage diabetes. They function by blocking the digestive enzymes that process complex carbohydrates into easily absorbed glucose, thus moderating post-prandial blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Voglidac 0.2 mg tablets is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Voglidac 0.2 mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Using Voglidac 0.2 mg tablets during breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Voglidac 0.2 mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Voglidac 0.2 Tablet MD cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Voglidac 0.2 mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Voglidac 0.2 Tablet MD :
Omit any missed Voglidac 0.2 mg tablet; resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglidac 0.2 Tablet MD
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |
